GALNF (Galenica) EPS without NRI: $4.55 (TTM As of Dec. 2025)


GALNF Galenica Ltd GALNF
80 GF Score
Price $115.00
GF Value $117.23
! 1 Warning Sign
View Full Analysis

What is Galenica EPS without NRI?

Galenica GALNF 80 EPS without NRI is $4.55 as of Dec. 2025. GuruFocus rates GALNF with a GF Score™ of 80/100 and a GF Value™ of $117.23. The stock has 1 warning sign investors should review. Among 103 Medical Distribution companies, Galenica ranks better than 51.46% on this metric.

Galenica's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $2.37. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $4.55.

During the past 12 months, Galenica's average earnings per share (NRI) Growth Rate was 4.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 5.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 1.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Galenica's EPS without NRI or its related term are showing as below:

GALNF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -3.6   Med: 7.1   Max: 22.9
Current: 5

During the past 13 years, Galenica's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 22.90% per year. The lowest was -3.60% per year. And the median was 7.10% per year.

GALNF's 3-Year EPS without NRI Growth Rate is ranked better than
51.46% of 103 companies
in the Medical Distribution industry
Industry Median: 2.6 vs GALNF: 5.00

Galenica's EPS (Diluted) for the six months ended in Dec. 2025 was $2.33. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $4.51.

Galenica's EPS (Basic) for the six months ended in Dec. 2025 was $2.33. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $4.51.


Galenica  (OTCPK:GALNF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Galenica EPS without NRI Related Terms


Galenica EPS without NRI Historical Data

* Premium members only.

The historical data trend for Galenica's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galenica EPS without NRI Chart

Galenica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.50 3.33 3.61 3.85 4.50

Galenica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 1.77 2.34 2.18 2.37

GALNF vs MCK, COR, CAH: EPS without NRI Comparison

For the Medical Distribution subindustry, Galenica's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galenica PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Galenica's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Galenica's PE Ratio without NRI falls into.


GALNF
80GF Score
Galenica Ltd GALNF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galenica EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $4.55 mean?
Galenica (GALNF) has a EPS without NRI of $4.55 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Galenica and its competitors. According to the industry distribution chart, Galenica ranks #50 out of 103 companies in the Medical Distribution industry, placing it in the top 48.5%.
Is Galenica's EPS without NRI too high?
Galenica's current EPS without NRI is $4.55. The Medical Distribution industry median EPS without NRI is 2.60. Galenica's value of $4.55 is 75% above this industry median. Based on the distribution chart, Galenica ranks #50 out of 103 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Galenica has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's EPS without NRI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Galenica ranks #50 out of 103 companies for EPS without NRI. This puts Galenica in the upper half of its industry. The industry median EPS without NRI is 2.60. Galenica's value of $4.55 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.60, based on 103 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current EPS without NRI of $4.55 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current EPS without NRI is $4.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current EPS without NRI of $4.55. The stock's GF Value™ is $117.23, compared to a current price of $115.00 — trading 1.9% below its estimated fair value. The current EPS without NRI is $4.55 and 75% above the Medical Distribution industry median of 2.60. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Galenica (GALNF), the current EPS without NRI is $4.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (GALNF) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be undervalued. The current stock price of $115.00 is trading 1.9% below its estimated GF Value™ of $117.23.

Key valuation signals for GALNF:

  • EPS without NRI: $4.55
  • GF Value™: $117.23 vs. price of $115.00 (1.9% below fair value)
  • GF Score™: 80/100 with 1 warning sign
  • Industry Position: 75% above the Medical Distribution median (#50 of 103)

No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
80GF Score

Get the complete analysis for GALNF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$115.00
Price
$117.23
GF Value